---
pmid: '17872974'
title: Plasmin-cleaved beta-2-glycoprotein 1 is an inhibitor of angiogenesis.
authors:
- Sakai T
- Balasubramanian K
- Maiti S
- Halder JB
- Schroit AJ
journal: Am J Pathol
year: '2007'
full_text_available: false
pmcid: PMC2043526
doi: 10.2353/ajpath.2007.070146
---

# Plasmin-cleaved beta-2-glycoprotein 1 is an inhibitor of angiogenesis.
**Authors:** Sakai T, Balasubramanian K, Maiti S, Halder JB, Schroit AJ
**Journal:** Am J Pathol (2007)
**DOI:** [10.2353/ajpath.2007.070146](https://doi.org/10.2353/ajpath.2007.070146)
**PMC:** [PMC2043526](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2043526/)

## Abstract

1. Am J Pathol. 2007 Nov;171(5):1659-69. doi: 10.2353/ajpath.2007.070146. Epub
2007  Sep 14.

Plasmin-cleaved beta-2-glycoprotein 1 is an inhibitor of angiogenesis.

Sakai T(1), Balasubramanian K, Maiti S, Halder JB, Schroit AJ.

Author information:
(1)The Department of Cancer Biology, The University of Texas, M. D. Anderson 
Cancer Center, Houston, TX, USA.

beta-2-Glycoprotein 1, an abundant plasma glycoprotein, binds anionic cell 
surfaces and functions as a regulator of thrombosis. Here, we show that cleavage 
of the kringle domain at Lys317/Thr318 switches its function to a regulator of 
angiogenesis. In vitro, the cleaved protein specifically inhibited the 
proliferation and migration of endothelial cells. The protein was without effect 
on preformed endothelial cell tubes. In vivo, the cleaved protein inhibited 
neovascularization into subcutaneously implanted Matrigel and Gelfoam sponge 
implants and the growth of orthotopically injected tumors. Collectively, these 
data indicate that plasmin-cleaved beta-2-glycoprotein 1 is a potent 
antiangiogenic and antitumor molecule of potential therapeutic significance.

DOI: 10.2353/ajpath.2007.070146
PMCID: PMC2043526
PMID: 17872974 [Indexed for MEDLINE]
